ESPB and RIB for Pain Management Following Mastectomy Surgery

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

February 16, 2021

Primary Completion Date

December 20, 2021

Study Completion Date

December 20, 2021

Conditions
Breast CancerBreast NeoplasmsBreast Cancer Female
Interventions
OTHER

Analgesia management; group ESPB and RIB

Patients will be administered ibuprofen 400 mgr IV every 8 hours in the postoperative period. A patient controlled device prepared with 10 mcg/ ml fentanyl will be attached to all patients with a protocol included 10 mcg bolus without infusion dose, 10 min lockout time and 4 hour limit. Postoperative patient evaluation will be performed by an anesthesiologist blinded to the procedure.

Trial Locations (1)

34070

Istanbul Medipol University Hospital, Istanbul

All Listed Sponsors
lead

Medipol University

OTHER

NCT04752150 - ESPB and RIB for Pain Management Following Mastectomy Surgery | Biotech Hunter | Biotech Hunter